Literature DB >> 6260656

Analysis and characterization of herpes simplex virus after its persistence in a lymphoblastoid cell line for 15 months.

L F Roumillat, P M Feorino, D D Caplan, P D Lukert.   

Abstract

Infection of a human lymphoblastoid cell line (F-365 line containing Epstein-Barr viral capsid antigen, derived from an individual without overt signs of lymphoma, infectious mononucleosis, or leukemia) with herpes simplex virus (HSV), maintained and observed for 15 months, was characterized by the continuous production of infectious extracellular virus. By the 5th day postinfection 75% of the cells produced HSV antigen as detected by fluorescent antibody, and by the 10th day 90% did so; production continued through the 15th month. Only 11% of single isolated cells produced detectable infectious virus. HSV produced after the 3rd month formed smaller plaque in monolayer cell culture than did the parental virus. No antigenic or polypeptide change in the HSV was detected by crossed immunoelectrophoresis and sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis over the 15-month cultivation in F-365 cells. Cell susceptibility and HSV virulence did not appear to change. The HSV-lymphoblastoid cell culture provided a useful model in which to study long-term virus-cell interactions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6260656      PMCID: PMC551179          DOI: 10.1128/iai.29.2.671-677.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  A persistent herpes simplex infection in antibody-free cell culture.

Authors:  V COLEMAN; E JAWETZ
Journal:  Virology       Date:  1961-03       Impact factor: 3.616

2.  Persistent infection with human cytomegalovirus in a lymphoblastoid cell line.

Authors:  T Furukawa
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

3.  Influence of genetic and physiological properties of the host cell on the cytopathic expression of herpes simplex virus.

Authors:  A M Palenzona; P Sinibaldi; F Costanzo; E Cassai
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

4.  Temperature-sensitive viruses and the etiology of chronic and inapparent infections.

Authors:  O T Preble; J S Youngner
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

5.  Analysis of herpes simplex virus type 1 antigens exposed on the surface of infected tissue culture cells.

Authors:  B Norrild; O J Bjerrum; H Ludwig; B F Vestergaard
Journal:  Virology       Date:  1978-06-15       Impact factor: 3.616

6.  Persistent infection with herpes simplex virus in vitro. 1. Establishment and characteristics of persistent herpes simplex virus infection in Earle's L cells.

Authors:  S Nii
Journal:  Biken J       Date:  1969-06

7.  Mechanism of persistent herpes simplex virus infection in vitro.

Authors:  B Hampar; M A Burroughs
Journal:  J Natl Cancer Inst       Date:  1969-09       Impact factor: 13.506

8.  Autogenous and virus-induced interferons from lines of lymphoblastoid cells.

Authors:  B A Zajac; W Henle; G Henle
Journal:  Cancer Res       Date:  1969-08       Impact factor: 12.701

9.  Epstein-Barr virus antigens, marker chromosome, and interferon production in clones derived from cultured Burkitt tumor cells.

Authors:  B A Zajac; G Kohn
Journal:  J Natl Cancer Inst       Date:  1970-08       Impact factor: 13.506

10.  Persistent Herpes Simplex Virus Infection In Vitro with Cycles of Cell Destruction and Regrowth.

Authors:  B Hampar; M L Copeland
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

View more
  7 in total

1.  Characterization of herpes simplex virus persistence in a human T lymphoblastoid cell line.

Authors:  P J Cummings; R J Lakomy; C R Rinaldo
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

2.  Persistent Varicella-Zoster virus infection in a human rhabdomyosarcoma cell line and recovery of a plaque variant.

Authors:  J P Iltis; J Vette; G A Castellano; D L Madden; J L Sever
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

3.  Alpha interferon and acyclovir treatment of herpes simplex virus in lymphoid cell cultures.

Authors:  S M Hammer; J C Kaplan; B R Lowe; M S Hirsch
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

4.  Herpes simplex virus type 1 long-term persistence, latency, and reactivation in infected Burkitt lymphoma cells.

Authors:  W Hampl; S Conrad; A K Kleinschmidt
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Herpes simplex virus persistence in mouse neuroblastoma (C 1300) cell cultures: role of interferon.

Authors:  G J Dawson; S L Mowshowitz; R Cohen; T S Elizan
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

6.  Monoclonal antibodies to a monkeypox virus polypeptide determinant.

Authors:  L F Roumillat; J L Patton; M L Davis
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

Review 7.  Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.

Authors:  Felipe Tapia; Daniel Vázquez-Ramírez; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2016-01-13       Impact factor: 4.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.